HEALTHJun 16 · 16:45 UTCSTAT NEWSMario Aguilar

STAT+: How a biotech turned a trial failure into an AI model

A biotech company transformed a failed clinical trial into an AI model, as reported in STAT's Health Tech newsletter. The article discusses how this approach is being used in the life sciences technology sector.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

STATorganizationHealth Tech newsletterorganizationAI modeltopicclinical trialtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSMay 18 · 13:11 UTC
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
HEALTHJun 11 · 12:05 UTC
STAT+: ‘Synthetic lethality’ could trigger another round of biotech M&A
HEALTHMay 8 · 13:37 UTC
STAT+: The biotech news you need to read today
HEALTHJun 4 · 05:11 UTC
Cancer Therapeutics Startup Earli on China Biotech Lead
HEALTHMay 21 · 23:39 UTC
STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial